This discrepancy may be attributed to the internal hypoxia characteristic of both organoid and animal models, which activates the hypoxia-inducible factor (HIF) pathway in tumor cells, thereby influencing their metabolism, proliferation, and receptor expression, including HER-2. This evidence concerns the gene ERBB2 and neoplasm.